← All organizations

Nitto Denko Corporation

For profitWebsite ↗

Also known as: Nitto Denko Corporation | This trial was conducted by the previous sponsor, Nitto Denko Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 18, 2018

Timeline

1910s

Jun 1, 1918
Nitto Denko Corporation— Founded

2010s

Feb 3, 2011
Avecia— Acquired
Apr 25, 2012
Altea Therapeutics— Acquired

Drugs by trial phase (4 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

lidocaine

Phase 2 (1 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

nsv0001

Indications

Studied for

Subsidiaries (2 direct, 4 total across the full acquisition tree)

Recent trials (6)

NCT03538301Study directorPhase 2Jun 18, 2018
NCT03538301Lead sponsorPhase 2Jun 18, 2018
NCT02955030Study chairPhase 1Oct 1, 2016
NCT02955030Lead sponsorPhase 1Oct 1, 2016
NCT03241264CollaboratorPhase 1Aug 28, 2016
NCT02061475CollaboratorPhase 2/Phase 3Apr 1, 2014

Details

Founded: Osaka, JP Jun 1, 1918
Last known activity: Jun 18, 2018